The global cytotoxic drugs market is estimated to grow at a significant CAGR during the forecast period. A huge increase in cancer rates and more awareness about cancer disorders are two important reasons driving the market's growth. According to the WHO,  cancer is the second leading cause of death globally, which accounted for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women.

The cancer burden continues to grow globally, exerting tremendous physical, emotional, and financial strain on individuals, families, communities, and health systems. Many health systems in low- and middle-income countries are least prepared to manage this burden, and large numbers of cancer patients globally, do not have access to timely quality diagnosis and treatment. In countries where health systems are strong, survival rates of many types of cancers are improving, thanks to accessible early detection, quality treatment, and survivorship care.

The global cytotoxic drugs market is classified based on drug class and application. Based on drug class, the market is classified into alkylating, antimetabolites, antitumor antibiotics, plant alkaloids, and others. Based on application, the market is classified into lung cancer, breast cancer, prostate cancer, pancreatic cancer, and others. 

Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America is estimated to witness significant growth during the forecast period, owing to the rising incidences of cancer and significant funding opportunity for cancer researches in the region.

The major players operating in the market include Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. To maintain a strong position in the market, these market players adopt various strategies such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in June 2019, Pfizer Inc. acquired Array BioPharma Inc., a commercial-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of targeted small molecule drugs, for the treatment of cancer and other diseases. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered

• Competitive Landscape: Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cytotoxic Drugs Market by Drug Class

o Alkylating 

o Antimetabolites

o Antitumor Antibiotics

o Plant Alkaloids

o Others

Global Cytotoxic Drugs Market by Application

o Lung Cancer

o Breast Cancer

o Prostate Cancer

o Pancreatic Cancer

o Others

Regional Analysis